208 related articles for article (PubMed ID: 20616902)
1. Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs).
Vetto JT
Onco Targets Ther; 2009 Feb; 2():151-9. PubMed ID: 20616902
[TBL] [Abstract][Full Text] [Related]
2. Ripretinib for the treatment of advanced gastrointestinal stromal tumor.
Zalcberg JR
Therap Adv Gastroenterol; 2021; 14():17562848211008177. PubMed ID: 33948116
[TBL] [Abstract][Full Text] [Related]
3. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
4. Current management of gastrointestinal stromal tumors--a comprehensive review.
Lai EC; Lau SH; Lau WY
Int J Surg; 2012; 10(7):334-40. PubMed ID: 22633986
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.
Nishida T; Doi T; Naito Y
Expert Opin Pharmacother; 2014 Oct; 15(14):1979-89. PubMed ID: 24990162
[TBL] [Abstract][Full Text] [Related]
6. Optimizing tyrosine kinase inhibitor therapy in gastrointestinal stromal tumors: exploring the benefits of continuous kinase suppression.
Le Cesne A; Blay JY; Reichardt P; Joensuu H
Oncologist; 2013; 18(11):1192-9. PubMed ID: 24136010
[TBL] [Abstract][Full Text] [Related]
7. Surgery for metastatic gastrointestinal stromal tumor: to whom and how to?
Kikuchi H; Hiramatsu Y; Kamiya K; Morita Y; Sakaguchi T; Konno H; Takeuchi H
Transl Gastroenterol Hepatol; 2018; 3():14. PubMed ID: 29682621
[TBL] [Abstract][Full Text] [Related]
8. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.
Keung EZ; Fairweather M; Raut CP
Curr Treat Options Oncol; 2016 Feb; 17(2):8. PubMed ID: 26820287
[TBL] [Abstract][Full Text] [Related]
9. Surgical Management of Metastatic Gastrointestinal Stromal Tumors.
Yonkus JA; Alva-Ruiz R; Grotz TE
Curr Treat Options Oncol; 2021 Mar; 22(5):37. PubMed ID: 33743084
[TBL] [Abstract][Full Text] [Related]
10. State of the Art in the Treatment of Gastrointestinal Stromal Tumors.
Garlipp B; Bruns CJ
Gastrointest Tumors; 2014 May; 1(4):221-36. PubMed ID: 26672673
[TBL] [Abstract][Full Text] [Related]
11. Budgetary impact of treatment with adjuvant imatinib for 1 year following surgical resection of Kit-positive localized gastrointestinal stromal tumors.
Rubin JL; Taylor DC; Sanon M; Coombs JH; Bollu VK
J Manag Care Pharm; 2010 Sep; 16(7):482-91. PubMed ID: 20726677
[TBL] [Abstract][Full Text] [Related]
12. Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours.
Naito Y; Nishida T; Doi T
Gastric Cancer; 2023 May; 26(3):339-351. PubMed ID: 36913072
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy in the treatment of gastrointestinal stromal tumor.
Knowlton CA; Brady LW; Heintzelman RC
Rare Tumors; 2011 Oct; 3(4):e35. PubMed ID: 22355490
[TBL] [Abstract][Full Text] [Related]
14. Management of Gastrointestinal Stromal Tumors.
Keung EZ; Raut CP
Surg Clin North Am; 2017 Apr; 97(2):437-452. PubMed ID: 28325196
[TBL] [Abstract][Full Text] [Related]
15. [Treatment strategy for marginally resectable GIST].
Kanda T; Ishikawa T; Ozaki T; Yajima K; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1266-70. PubMed ID: 21829064
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)-review and perspectives.
Laurent M; Brahmi M; Dufresne A; Meeus P; Karanian M; Ray-Coquard I; Blay JY
Transl Gastroenterol Hepatol; 2019; 4():24. PubMed ID: 31143845
[TBL] [Abstract][Full Text] [Related]
17. Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.
Sjölund K; Andersson A; Nilsson E; Nilsson O; Ahlman H; Nilsson B
World J Surg; 2010 Sep; 34(9):2090-7. PubMed ID: 20512492
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of tyrosine kinase inhibitor therapy in metastatic gastrointestinal stromal tumors.
Blanke CD; Huse DM
J Med Econ; 2010; 13(4):681-90. PubMed ID: 21067355
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy in primary GIST: state-of-the-art.
Reichardt P; Blay JY; Boukovinas I; Brodowicz T; Broto JM; Casali PG; Decatris M; Eriksson M; Gelderblom H; Kosmidis P; Le Cesne A; Pousa AL; Schlemmer M; Verweij J; Joensuu H
Ann Oncol; 2012 Nov; 23(11):2776-2781. PubMed ID: 22831984
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy and personalized medicine in gastrointestinal stromal tumors: drug resistance, mechanisms, and treatment strategies.
Li GZ; Raut CP
Onco Targets Ther; 2019; 12():5123-5133. PubMed ID: 31308690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]